Novel Lipophagy Inducers as Potential Therapeutics for Lipid Metabolism Disorders
ACS Chemical Biology · 20.06.2025 · 20 (6) · 1406-1416
DOI: 10.1021/acschembio.5c00212 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 02.06.2025. Verfasst von Rachel Njeim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, Uni…. Hauptthemen laut MEDLINE: Autophagy, Small Molecule Libraries, Lipid Metabolism Disorders, Lipid Metabolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Onco-Genomics Shared Resource of the Sylvester Comprehensive Cancer Center, University of Miami.
Abstract (Originalsprache)
Dysregulation of lipid homeostasis is associated with a wide range of pathologies encompassing neurological, metabolic, cardiovascular, oncological, and renal disorders. We previously showed that lipid droplet (LD) accumulation in podocytes contributes to the progression of diabetic kidney disease (DKD) and reducing LDs preserves podocyte function and prevents albuminuria. Here, we sought to identify compounds that treat pathological LD accumulation. We developed a phenotypic assay using human podocytes and deployed it to screen a combinatorial library comprising over 45 million unique small molecules. This led to the identification of a compound series that effectively reduces LD accumulation in stressed podocytes. Mechanistic studies revealed that these compounds activate lipophagy, reduce LD accumulation, and rescue podocytes from cell death. In contrast, compounds known to induce general autophagy failed to mimic these effects, indicating a novel lipophagy-specific mechanism of action (MoA), which was confirmed by unbiased phenotypic profiling. An advantage of this therapeutic strategy is its potential to not only halt the progression of pathological lipid accumulation but also reverse it. These compounds will serve as tools for uncovering novel drug targets and therapeutic MoAs for treating DKD and other diseases with similar etiologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
- Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
- The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
- Center for Translational Science, Florida International University, Port St. Lucie, Florida 34987, United States.
- Department of Medicinal Chemistry & Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
ORCID-Profile: Rachel Njeim, Bassel Awada, Hassan Al-Ali
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Onco-Genomics Shared Resource of the Sylvester Comprehensive Cancer Center, University of Miami
- Peggy and Harold Katz Drug Discover Center, University of Miami
Zitieren
APA
Njeim, R., Awada, B., Donow, H., Gye, H., Foster, C., Kelly, C., Molina, J., Merscher, S., Giulianotti, M., Fornoni, A., & Al-Ali, H. (2025). Novel Lipophagy Inducers as Potential Therapeutics for Lipid Metabolism Disorders. ACS Chemical Biology, 20(6), 1406-1416. https://doi.org/10.1021/acschembio.5c00212
Vancouver
Njeim R, Awada B, Donow H, Gye H, Foster C, Kelly C, et al. Novel Lipophagy Inducers as Potential Therapeutics for Lipid Metabolism Disorders. ACS Chemical Biology. 2025;20(6):1406-1416. doi:10.1021/acschembio.5c00212
BibTeX
@article{Njeim2025,
author = {Njeim, Rachel and Awada, Bassel and Donow, Haley and Gye, Haley and Foster, Cole and Kelly, Colin and Molina, Judith and Merscher, Sandra and Giulianotti, Marcello and Fornoni, Alessia and Al-Ali, Hassan},
title = {Novel Lipophagy Inducers as Potential Therapeutics for Lipid Metabolism Disorders},
journal = {ACS Chemical Biology},
year = {2025},
volume = {20},
number = {6},
pages = {1406--1416},
doi = {10.1021/acschembio.5c00212}
}
EUVIMED